Skip to content
Menu
Menu

Go Beyond Medications. Consider Zephyr Valves for Severe COPD/Emphysema. 

Zephyr Valves are Proven to Improve Breathing and Quality of Life1

See How It Works:

The Zephyr® Valve received FDA approval in 2018, and with over 25,000 patients treated globally, it is proven to help improve lung function, exercise capacity, and quality of life — without traditional surgery and many of its associated risks.20

Complications of the Zephyr Endobronchial Valve treatment can include but are not limited to pneumothorax, worsening of COPD symptoms, hemoptysis, pneumonia, dyspnea and, in rare cases, death.

We’re Here to Help! Sign Up to Get More Information and Support.

"*" indicates required fields

Name*
Zip Code*
Are You A:*
You are opting in to receive future communications about severe COPD/emphysema and the Zephyr Valve.
Hidden
Hidden
This field is for validation purposes and should be left unchanged.

A Guide To Talking with Your Doctor About Zephyr Valves

Information for Physicians to Refer Patients for Treatment

Who Might Qualify?

Patients who meet the following criteria should be evaluated for treatment with endobronchial valves:1–5

  • Breathless despite optimal medical management (mMRC≥2)
  • A confirmed diagnosis of COPD
  • Non-smoking or willing to quit smoking
  • Have an FEV1 ≤50% predicted

For more detailed information on clinical data and patient selection criteria please download our free resources.

Zephyr-Valve
2020-GOLD-Evidence-A-Zephyr-Valve
Patients-treated-globally

GOLD 2020: Level A Evidence rating affirms that endobronchial valves, like the Zephyr Valve, are a viable, minimally invasive treatment option for severe emphysema, a form of COPD.

Patient Stories

US-EN-1493-v1